Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

Zenapax enters clinical trials for uveitis

Nov. 1, 1996

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

PDL signs agreement with Roche for humanized antibody

Nov. 1, 1996

Collagenase inhibitor from Roche for arthritic conditions

Nov. 1, 1996

Antiarthritic agents reported by Kaken

Nov. 1, 1996

ADIR investigates COX-2 inhibitors

Nov. 1, 1996

Key lupus patent issued to Genelabs

Oct. 25, 1996

AM-425 available for licensing

Oct. 25, 1996

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...